Plandai Biotech Stock Market Value
| PLPL Stock | USD 0.0001 0.00 0.00% |
| Symbol | Plandai |
Plandai Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Plandai Biotech's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Plandai Biotech.
| 12/16/2024 |
| 03/16/2025 |
If you would invest 0.00 in Plandai Biotech on December 16, 2024 and sell it all today you would earn a total of 0.00 from holding Plandai Biotech or generate 0.0% return on investment in Plandai Biotech over 90 days. Planda Biotechnology, Inc. focuses on the production of proprietary botanical extracts for the nutriceutical and pharmac... More
Plandai Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Plandai Biotech's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Plandai Biotech upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.2325 | |||
| Maximum Drawdown | 1100.0 | |||
| Value At Risk | (100.00) | |||
| Potential Upside | 1000.0 |
Plandai Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Plandai Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Plandai Biotech's standard deviation. In reality, there are many statistical measures that can use Plandai Biotech historical prices to predict the future Plandai Biotech's volatility.| Risk Adjusted Performance | 0.2121 | |||
| Jensen Alpha | 53.41 | |||
| Total Risk Alpha | 91.08 | |||
| Treynor Ratio | (1.12) |
Plandai Biotech Backtested Returns
Plandai Biotech is out of control given 3 months investment horizon. Plandai Biotech maintains Sharpe Ratio (i.e., Efficiency) of 0.23, which implies the firm had a 0.23 % return per unit of risk over the last 3 months. We were able to interpolate data for eighteen different technical indicators, which can help you to evaluate if expected returns of 58.2% are justified by taking the suggested risk. Use Plandai Biotech Risk Adjusted Performance of 0.2121, variance of 64956.92, and Coefficient Of Variation of 430.76 to evaluate company specific risk that cannot be diversified away. Plandai Biotech holds a performance score of 18 on a scale of zero to a hundred. The company holds a Beta of -52.72, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Plandai Biotech are expected to decrease by larger amounts. On the other hand, during market turmoil, Plandai Biotech is expected to outperform it. Use Plandai Biotech market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness , to analyze future returns on Plandai Biotech.
Auto-correlation | -0.37 |
Poor reverse predictability
Plandai Biotech has poor reverse predictability. Overlapping area represents the amount of predictability between Plandai Biotech time series from 16th of December 2024 to 30th of January 2025 and 30th of January 2025 to 16th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Plandai Biotech price movement. The serial correlation of -0.37 indicates that just about 37.0% of current Plandai Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.37 | |
| Spearman Rank Test | 0.73 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Plandai Biotech lagged returns against current returns
Autocorrelation, which is Plandai Biotech pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Plandai Biotech's pink sheet expected returns. We can calculate the autocorrelation of Plandai Biotech returns to help us make a trade decision. For example, suppose you find that Plandai Biotech has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Plandai Biotech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Plandai Biotech pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Plandai Biotech pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Plandai Biotech pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Plandai Biotech Lagged Returns
When evaluating Plandai Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Plandai Biotech pink sheet have on its future price. Plandai Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Plandai Biotech autocorrelation shows the relationship between Plandai Biotech pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Plandai Biotech.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Plandai Pink Sheet
Plandai Biotech financial ratios help investors to determine whether Plandai Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Plandai with respect to the benefits of owning Plandai Biotech security.